Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 268.00 | 260.00 | 1.0308 | 1.0816 |
| BT-20 | Linsitinib | 10 | uM | 9 | 312.50 | 153.73 | 232.00 | 260.00 | 0.8923 | 0.7209 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 312.50 | 153.73 | 289.00 | 260.00 | 1.1115 | 1.2994 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 398.00 | 260.00 | 1.5308 | 2.5070 |
| BT-20 | Erlotinib | 1 | uM | 9 | 312.50 | 153.73 | 314.00 | 260.00 | 1.2077 | 1.5653 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 312.50 | 153.73 | 180.00 | 260.00 | 0.6923 | 0.2314 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 400.00 | 260.00 | 1.5385 | 2.5302 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 312.50 | 153.73 | 366.00 | 260.00 | 1.4077 | 2.1399 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 372.00 | 260.00 | 1.4308 | 2.2080 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 488.00 | 260.00 | 1.8769 | 3.5889 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 312.50 | 153.73 | 355.00 | 260.00 | 1.3654 | 2.0160 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 255.00 | 260.00 | 0.9808 | 0.9494 | |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 312.50 | 153.73 | 314.00 | 260.00 | 1.2077 | 1.5653 |
| BT-20 | Erlotinib | 10 | uM | 9 | 312.50 | 153.73 | 259.00 | 260.00 | 0.9962 | 0.9899 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 312.50 | 153.73 | 372.00 | 260.00 | 1.4308 | 2.2080 |
| BT-20 | Lapatinib | 10 | uM | 9 | 312.50 | 153.73 | 116.00 | 260.00 | 0.4462 | -0.3103 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 289.00 | 260.00 | 1.1115 | 1.2994 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 304.00 | 260.00 | 1.1692 | 1.4581 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 312.50 | 153.73 | 276.00 | 260.00 | 1.0615 | 1.1639 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 260.00 | 260.00 | 1.0000 | 1.0000 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 207.00 | 260.00 | 0.7962 | 0.4806 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 312.50 | 153.73 | 231.00 | 260.00 | 0.8885 | 0.7111 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 252.00 | 260.00 | 0.9692 | 0.9192 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 312.50 | 153.73 | 123.00 | 260.00 | 0.4731 | -0.2548 |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 165.00 | 260.00 | 0.6346 | 0.0978 |